MARKET

NAMS

NAMS

NewAmsterdam Pharma Company N.V
NASDAQ
35.26
-0.59
-1.65%
After Hours: 35.00 -0.26 -0.74% 18:50 12/05 EST
OPEN
35.82
PREV CLOSE
35.85
HIGH
36.15
LOW
34.70
VOLUME
1.21M
TURNOVER
--
52 WEEK HIGH
42.00
52 WEEK LOW
14.06
MARKET CAP
4.00B
P/E (TTM)
-17.4641
1D
5D
1M
3M
1Y
5Y
1D
NewAmsterdam Pharma Price Target Raised to $37.00/Share From $30.00 by Goldman Sachs
Dow Jones · 3d ago
NewAmsterdam Pharma Is Maintained at Neutral by Goldman Sachs
Dow Jones · 3d ago
Goldman Sachs Maintains Neutral on NewAmsterdam Pharma Co, Raises Price Target to $37
Benzinga · 3d ago
NewAmsterdam Pharma price target raised to $37 from $30 at Goldman Sachs
TipRanks · 3d ago
Weekly Report: what happened at NAMS last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at NAMS last week (1117-1121)?
Weekly Report · 11/24 10:21
Weekly Report: what happened at NAMS last week (1110-1114)?
Weekly Report · 11/17 10:20
NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating
Seeking Alpha · 11/16 15:30
More
About NAMS
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMS stock methods without spending real money on the virtual paper trading platform.